Results 71 to 80 of about 32,346 (134)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
New England Journal of Medicine, 2008 J. S. San Miguel, R. Schlag, Nuriet K. Khuageva, M. Dimopoulos, O. Shpilberg, M. Kropff, I. Špička, M. Petrucci, A. Palumbo, O. Samoilova, A. Dmoszyńska, K. Abdulkadyrov, R. Schots, B. Jiang, M. Mateos, K. Anderson, D. Esseltine, Kevin X. Liu, A. Cakana, H. van de Velde, P. Richardson +20 moresemanticscholar +1 more sourceLenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.
Journal of Clinical Oncology, 2017 P. McCarthy, S. Holstein, M. Petrucci, P. Richardson, C. Hulin, P. Tosi, S. Bringhen, P. Musto, K. Anderson, D. Caillot, F. Gay, P. Moreau, G. Marit, Sin-Ho Jung, Zhinuan Yu, B. Winograd, R. Knight, A. Palumbo, M. Attal +18 moresemanticscholar +1 more sourceContinuous lenalidomide treatment for newly diagnosed multiple myeloma.
New England Journal of Medicine, 2012 A. Palumbo, R. Hájek, M. Delforge, M. Kropff, M. Petrucci, J. Catalano, H. Gisslinger, W. Wiktor-Jedrzejczak, M. Zodelava, K. Weisel, N. Cascavilla, G. Iosava, M. Cavo, J. Kłoczko, J. Bladé, M. Beksaç, I. Špička, T. Plesner, J. Radke, C. Langer, D. Ben Yehuda, A. Corso, Lindsay Herbein, Zhinuan Yu, J. Mei, C. Jacques, M. Dimopoulos +26 moresemanticscholar +1 more source